KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Receivables - Net (2016 - 2025)

Boston Scientific (BSX) has disclosed Receivables - Net for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 9.71% to $2.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2025, up 9.71% year-over-year, with the annual reading at $2.9 billion for FY2025, 9.71% up from the prior year.
  • Receivables - Net hit $2.9 billion in Q4 2025 for Boston Scientific, up from $2.8 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $2.9 billion in Q4 2025 to a low of $1.7 billion in Q3 2021.
  • Historically, Receivables - Net has averaged $2.3 billion across 5 years, with a median of $2.2 billion in 2023.
  • Biggest YoY gain for Receivables - Net was 22.24% in 2021; the steepest drop was 4.44% in 2021.
  • Year by year, Receivables - Net stood at $1.9 billion in 2021, then rose by 10.23% to $2.1 billion in 2022, then increased by 12.46% to $2.3 billion in 2023, then grew by 14.07% to $2.7 billion in 2024, then increased by 9.71% to $2.9 billion in 2025.
  • Business Quant data shows Receivables - Net for BSX at $2.9 billion in Q4 2025, $2.8 billion in Q3 2025, and $2.8 billion in Q2 2025.